Latest News
- AVI BioPharma — Investor and Analyst Breakfast Schedule September 8, 2008, PORTLAND, Ore.
- AVI BioPharma to Host Analyst & Investor Breakfast Meeting September 8, 2008, PORTLAND, Ore.
- AVI BioPharma Announces Approval to Conduct Systemic Trial for Duchenne Muscular Dystrophy and Second Quarter 2008 Financial Results August 11, 2008, PORTLAND, Ore.